4.7 Article

Risk of Pregnancy in Moderate and Severe Aortic Stenosis From the Multinational ROPAC Registry

期刊

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
卷 68, 期 16, 页码 1727-1737

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jacc.2016.07.750

关键词

fetal outcome; heart failure; maternal outcome; risk factors

资金

  1. Abbott Vascular Int.
  2. Amgen
  3. AstraZeneca
  4. Bayer Pharma AG
  5. Boehringer Ingelheim
  6. Boston Scientific
  7. Bristol-Myers Squibb
  8. Pfizer Alliance
  9. Alliance Daiichi-Sankyo Europe GmbH
  10. Eli Lilly and Company
  11. Gedeon Richter Plc.
  12. Menarini Int. Op.
  13. MSD-Merck Co.
  14. Novartis Pharma AG
  15. ResMed
  16. Sanofi
  17. SERVIER

向作者/读者索取更多资源

BACKGROUND Controversial results on maternal risk and fetal outcome have been reported in women with aortic stenosis (AS). OBJECTIVES The authors sought to investigate maternal and fetal outcomes in patients with AS in a large cohort. METHODS The Registry on Pregnancy and Cardiac Disease (ROPAC) is a global, prospective observational registry of women with structural heart disease, providing a uniquely large study population. Data of women with moderate (peak gradient 36 to 63 mm Hg) and severe AS (peak gradient >= 64 mm Hg) were analyzed. RESULTS Of 2,966 pregnancies in ROPAC, the authors identified 96 women who had at least moderate AS (34 with severe AS). No deaths were observed during pregnancy and in the first week after delivery. However, 20.8% of women were hospitalized for cardiac reasons during pregnancy. This was significantly more common in severe AS compared with moderate AS (35.3% vs. 12.9%; p = 0.02), and reached the highest rate (42.1%) in severe, symptomatic AS. Pregnancy was complicated by heart failure in 6.7% of asymptomatic and 26.3% of symptomatic patients, but could be managed medically, except for 1 patient who was symptomatic before pregnancy and underwent balloon valvotomy. Children of patients with severe AS had a significantly higher percentage of low birth weight (35.0% vs. 6.0%; p = 0.006). CONCLUSIONS Mortality in pregnant women with AS, including those with severe AS, appears to be close to zero in the current era. Symptomatic and severe AS does, however, carry a substantial risk of heart failure and is associated with high rates of hospitalization for cardiac reasons, although heart failure can nearly always be managed medically. The results highlight the importance of appropriate pre-conceptional patient evaluation and counseling. (C) 2016 by the American College of Cardiology Foundation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据